NEU neuren pharmaceuticals limited

Ann: Neuren completes Phase 2 trial in pediatric Rett syndrome, page-22

  1. 9,630 Posts.
    lightbulb Created with Sketch. 349
    It's just baffling that they talk about dealing commercially with partners etc,but dont know the results yet.You dont even mention talking to anyone if you dont have some level of confidence in the drug.I know they have mentioned talking to potential partners before,but never at this stage.It would make the company look pretty silly to do so,so I can only suggest,they have a good grasp on the results.Hey maybe I'll be wrong,but can anyone explain it to me any differently?
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$14.20
Change
0.890(6.69%)
Mkt cap ! $1.761B
Open High Low Value Volume
$13.50 $14.26 $12.96 $9.111M 655.8K

Buyers (Bids)

No. Vol. Price($)
1 2000 $14.17
 

Sellers (Offers)

Price($) Vol. No.
$14.23 3278 1
View Market Depth
Last trade - 16.15pm 27/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.